CSI Market
Sign In | Register

Fulcrum Therapeutics Inc (FULC) Annual Balance Sheets

Annual · GAAP · USD millions
Access FULC quarterly Balance Sheets →
The data below summarizes Fulcrum Therapeutics Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent197.53
Marketable Securities, Total MA154.77
Cash & Short-term Investments351.00
Accounts receivable0.00
Unbilled Receivables, Current RE0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.17
Total Current Assets357.48
Equipment/Property/Plant Net2.82
Other Assets, Noncurrent5.98
Restricted Cash Noncurrent1.20
Total Assets366.28
Liabilities
Accounts Payable, Current AC1.59
Lease Incentive, Payable, Current0.00
Other Liabilities, Current11.46
Deferred Revenue, Current DE0.00
Total Current Liabilities13.05
Total Long-term Debt0.00
Deferred credits, Noncurrent0.00
Other liabilities, Noncurrent4.24
Operating Lease Liability Current2.40
Operating Lease Liability Noncurrent4.04
Lease Incentive Payable Noncurrent-
Total Liabilities17.28
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock943.04
Retained Earnings / Accumulated Deficit-594.28
Other Equity0.17
Common Stockholder's Equity349.00
Total Stockholder's Equity349.00
Liabilities & Stockholder's Equity366.28
4 historic quarters locked

Sign in to unlock the full Fulcrum Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Fulcrum Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: fulc-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-065197

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.